The World Health Organization (WHO) recommends that typhoid conjugate vaccines (TCVs) be used in outbreak settings. TCVs have successfully been implemented during outbreaks in Pakistan and Zimbabwe; however, current data ...
Read more
Author: Maile Phillips, Yale School of Public Health
Newly available genomic data highlights the need for urgent action to stop the emergence and spread of drug-resistant typhoid
For many high-income countries, typhoid is a disease of the past, thanks in part to municipal investments and improvements in safe water, sanitation, and hygiene infrastructure (WASH). However, one-third of ...
Read more
Celebrating women in typhoid
For International Women’s Day this year, we are celebrating some of the women who have dedicated their careers to take on typhoid. They are extraordinary researchers, scientists, doctors, global experts, ...
Read more
TCV introduction costs in Navi Mumbai municipality: An important factor for new vaccine introduction decision-making
Decision-makers in Gavi, the Vaccine Alliance-eligible countries have the monumental task of considering a portfolio of public health interventions and deciding which tools to prioritize for the greatest health impact. ...
Read more
Illegal mining in Ghana: The negative impact on WASH, typhoid, and other infectious diseases
Mining in Ghana The mining sector has historically been one of the major economic activities that contribute to national growth. Many countries have grown their economic stature by extrapolating natural ...
Read more
A glance at the past and looking forward to 2023
The year 2018 was full of monumental milestones and 2019 a year to celebrate. In spite of COVID, 2020 and 2021 brought great strides to the typhoid field. As we ...
Read more
Prioritizing TCV introduction in Africa: Time for decision-makers to act with urgency
As another year draws to a close, policymakers, researchers, and partners are convening in South Africa to discuss typhoid, TCV, and the work that remains to combat this disease. Despite ...
Read more
Typhoid takes a spotlight during the 2022 VASE Conference
VASE expands its scope Hundreds of scientists, public health professionals, immunization leaders, vaccine industry representatives, international donors, and other global experts gathered in Washington D.C. for the 2022 Vaccines Against ...
Read more
Test-negative design proves to be suitable for typhoid vaccine effectiveness evaluations
Background on test-negative design Typhoid continues to be a public health threat in sub-Saharan Africa. However, typhoid conjugate vaccine (TCV) is a proven intervention to reduce the burden of typhoid ...
Read more
Understanding the cost of typhoid in Malawi
Getting sick comes with costs—both physical as well as economic. Treatment costs and lost wages while recuperating or taking care of a sick family member can be detrimental to families. ...
Read more
